dihydrotestosterone has been researched along with Cardiometabolic Syndrome in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aflatounian, A; Bertoldo, MJ; Cochran, BJ; Edwards, MC; Gilchrist, RB; Ledger, WL; Paris, VR; Richani, D; Walters, KA; Wu, LE | 1 |
| Baccini, M; Bartolomeo, N; Carbone, MD; De Pergola, G; Di Dalmazi, G; Fanelli, F; Giagulli, VA; Pagotto, U; Pasquali, R; Pelusi, C; Triggiani, V | 1 |
| Culig, Z; Madersbacher, S; Sampson, N | 1 |
| Li, MX; Sun, LF; Xiao, TX; Yang, YL; Zhang, JV | 1 |
| Brabant, G; Harger, A; Hofer, D; Keevil, B; Lerchbaum, E; Münzker, J; Obermayer-Pietsch, B; Owen, L; Pieber, T; Trummer, C; Ulbing, M | 1 |
| Cohen, AS; Hougaard, DM; Jørgensen, JO; Kjaer, TN; Neghabat, S; Ornstrup, MJ; Pedersen, SB; Poulsen, MM; Richelsen, B | 1 |
| Davis, DD; Lima, R; Lockhart, R; Moulana, M; Racusen, LC; Reckelhoff, JF; Romero, DG; Yanes, LL; Zhang, H | 1 |
| Bendlová, B; Dušková, M; Hill, M; Meloun, M; Pospíšilová, H; Stárka, L; Vaňková, M | 1 |
1 review(s) available for dihydrotestosterone and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Pathophysiology of Benign Prostatic Hyperplasia and Benign Prostatic Enlargement: A Mini-Review.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Aging; Diabetes Mellitus; Dihydrotestosterone; Dutasteride; Dyslipidemias; Finasteride; Humans; Inflammation; Lower Urinary Tract Symptoms; Male; Metabolic Syndrome; Prostatic Hyperplasia; Receptors, Androgen | 2019 |
2 trial(s) available for dihydrotestosterone and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels.
Topics: Adult; Anti-Mullerian Hormone; Clomiphene; Cross-Over Studies; Diabetes Mellitus, Type 2; Dihydrotestosterone; Double-Blind Method; Drug Therapy, Combination; Estradiol; Estrogen Antagonists; Follow-Up Studies; Humans; Hypoglycemic Agents; Hypogonadism; Inhibins; Male; Metabolic Syndrome; Metformin; Middle Aged; Obesity; Sertoli Cells; Testosterone | 2020 |
Resveratrol reduces the levels of circulating androgen precursors but has no effect on, testosterone, dihydrotestosterone, PSA levels or prostate volume. A 4-month randomised trial in middle-aged men.
Topics: Aged; Androgens; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Dihydrotestosterone; Double-Blind Method; Humans; Male; Metabolic Syndrome; Middle Aged; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Regression Analysis; Resveratrol; Stilbenes; Testosterone; Testosterone Congeners | 2015 |
5 other study(ies) available for dihydrotestosterone and Cardiometabolic Syndrome
| Article | Year |
|---|---|
Declining muscle NAD
Topics: Animals; Dihydrotestosterone; Female; Humans; Hyperandrogenism; Insulin Resistance; Lipids; Metabolic Syndrome; Mice; Muscle, Skeletal; NAD; Nicotinamide Mononucleotide; Obesity; Polycystic Ovary Syndrome | 2022 |
Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice.
Topics: Adipose Tissue; Animals; Dihydrotestosterone; Disease Models, Animal; Disease Progression; Female; Gene Expression; Hyperandrogenism; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Ovary; Polycystic Ovary Syndrome; Stimulation, Chemical; Time Factors | 2019 |
Testosterone to dihydrotestosterone ratio as a new biomarker for an adverse metabolic phenotype in the polycystic ovary syndrome.
Topics: Adolescent; Adult; Biomarkers; Dihydrotestosterone; Female; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Metabolic Syndrome; Middle Aged; Polycystic Ovary Syndrome; Testosterone; Young Adult | 2015 |
Cardiovascular-renal and metabolic characterization of a rat model of polycystic ovary syndrome.
Topics: Angiotensinogen; Animals; Blood Glucose; Blood Pressure; Cardiovascular Diseases; Dihydrotestosterone; Disease Models, Animal; Estradiol; Female; Glomerular Filtration Rate; Glucose Tolerance Test; Kidney Diseases; Leptin; Metabolic Syndrome; Oxidative Stress; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2011 |
The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men.
Topics: Adult; Aged; Androgens; Body Composition; Dihydrotestosterone; Glucose Tolerance Test; Humans; Male; Metabolic Syndrome; Middle Aged; Obesity; Testosterone; Young Adult | 2012 |